COMMUNIQUÉS West-GlobeNewswire

KFSHRC Reduces Emergency Department Inpatient Bed Waiting Time by 75%
15/09/2025
RIYADH, Saudi Arabia, Sept. 15, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh has reduced the median emergency department boarding time from over 13 hours in 2023 to [...]
Sienna Announces September Dividend
15/09/2025
MARKHAM, Ontario, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “ Common Share ”) [...]
Actinogen achieves agreement with the FDA in a Type C meeting on the manufacturing, clinical and nonclinical activities required for a future US marketing approval of Xanamem for Alzheimer’s disease
15/09/2025
Current XanaMIA pivotal phase 2/3 trial on track for interim analysis in January 2026 and final results late 2026 with trial enrolment expected to close in Q4 2025 SYDNEY, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Actinogen [...]
Emergent BioSolutions Secures $17 Million Contract Modification for Oral Suspension TEMBEXA® (brincidofovir), a Smallpox Antiviral, and Strengthens Overall U.S. Supply Chain
15/09/2025
GAITHERSBURG, Md., Sept. 15, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has received a $17 million contract modification from the Biomedical Advanced Research and Development [...]
Press Release Biocartis NV: Biocartis Receives FDA Approval for the Idylla™ CDx MSI Test
15/09/2025
PRESS RELEASE - 09/15/2025, 09:00 AM EDT Biocartis Receives FDA Approval for the Idylla™ CDx MSI Test First-ever fully automated, sample-to-result, cartridge-based companion diagnostic test approved in the US for [...]
Entera Bio Reports Positive PK Data for First-in-Class Oral GLP-2 Tablet Treatment for Patients with Short Bowel Syndrome at the 2025 ESPEN Congress
15/09/2025
Preclinical Data for OPK-8801003 Demonstrate Substantially Longer Biological Half-Life with Peak Plasma Levels Comparable to Gattex ® , the Only Approved GLP-2 Therapy Oral GLP-2 Tablet Could Transform Treatment [...]
Conceivable Life Sciences Secures $50 Million Series A
15/09/2025
Funding supports U.S. market launch of AURA, World’s first AI-powered automated IVF lab NEW YORK, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Conceivable Life Sciences today announced its $50 million Series A financing to [...]
Assertio Presents First-Ever Real-World Study Showing Patient Experience with SYMPAZAN® (clobazam) Oral Film, CIV
15/09/2025
New data show how Sympazan is being used in daily clinical practice to treat patients with Lennox-Gastaut Syndrome (LGS), a severe form of childhood-onset epilepsy Study addresses lack of awareness and real-world data [...]
Botany Scientifics Wins “Top Full Spectrum Hemp Products 2025” Award from Cannabis Business Insights Magazine
15/09/2025
Texas hemp company recognized for exceptional quality, precision dosing, and pioneering consumer education SAN ANTONIO, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Botany Scientifics, a family-owned Texas hemp company [...]
Berry Street Launches GLP-1 Nutrition Pathway Program
15/09/2025
New Comprehensive Program Supports Patients Throughout Entire GLP-1 Journey NEW YORK, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Berry Street , an AI-powered nutrition therapy platform, today announced the launch of its GLP-1 [...]
Interpace Biosciences Presented Two New Posters at the 2025 American Thyroid Association® (ATA) Annual Meeting
15/09/2025
Highlights Independent institutional experience shows archival cytology slides enabled successful molecular results in cases previously insufficient for testing by another commercially available molecular diagnostic [...]
ProteoNic Launches 2G UNic Transposon Platform to Support Superior Cell Line Productivity and Ease of Use
15/09/2025
Leiden, The Netherlands – September 15, 2025 – ProteoNic , a leader in premium vector technology for biologics and cell and gene therapy, today announced the launch of its novel 2G UNic® transposon platform, available [...]
Soleo Health Promotes Holly Flax to Chief Operating Officer
15/09/2025
FRISCO, Texas, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Soleo Health , an innovative leader and national provider of complex specialty pharmacy services, announced today the promotion of Holly Flax to the post of chief [...]
Ocugen, Inc. and Kwangdong Pharmaceutical Co., Ltd. Complete License Agreement of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea
15/09/2025
Upfront fees and near-term development milestone payments totaling up to $7.5 million Potential sales milestones of $180 million or more in first 10 years of commercialization Royalties equaling 25% of net sales Ocugen [...]
CMS Posts Preliminary Payment Determination for New Category I CPT Code Covering Use of OGM for Constitutional Genetic Disorders
15/09/2025
SAN DIEGO, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (Nasdaq: BNGO) offering CLIA-certified laboratory developed tests (LDTs) based on optical genome [...]
Can-Fite Reports Complete Resolution of Esophageal Varices in Decompensated Cirrhosis Patient Treated with Namodenoson
15/09/2025
Ramat Gan, Israel, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs targeting oncological [...]
Humacyte Announces Publication of Outcomes for Patients with Hospital-Acquired Vascular Complications Treated with Symvess™
15/09/2025
- Results were published in the Journal of Vascular Surgery - - Publication described treatment of patients with Symvess who had hospital-acquired iatrogenic injuries or complications of vascular surgical procedures [...]
Harrow Announces Agenda and Speakers for Investor & Analyst Day
15/09/2025
NASHVILLE, Tenn., Sept. 15, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced the agenda for its upcoming Investor & [...]
Verano Holdings Corp. Announces Proposed Redomicile of Parent Company from British Columbia to Nevada
15/09/2025
CHICAGO, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Verano Holdings Corp . (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced that the Company’s Board of [...]

Pages